Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=amjd03158&nav=abs

Mosby Periodicals Home Search User
Pref
Help
JAAD Home Table of
Contents
All Issues Order About this
Journal
<<
Issue
>>
Issue


 

 

   

May 2003, part 2 • Volume 48 • Number 5

 


 

Case Reports
Juvenile sarcoidosis after BCG vaccination

Genevieve E. N. Osborne, MRCP [MEDLINE LOOKUP]
Eleanor Mallon, MRCP [MEDLINE LOOKUP]
Susan C. Mayou, BSc, FRCP [MEDLINE LOOKUP]
London, United Kingdom

Previous article in Issue
Next article in Issue
• View full-text version
• View print version (PDF)
Drug links from Mosby's DrugConsult
Genetic information from OMIM
• Citation of this Article
   • View on PubMed
   • Download in citation manager format
   • Download in Medlars format
Related articles in PubMed
 


 

   Abstract  TOP 

We report the case of a 2-year-old boy with juvenile sarcoidosis, in whom the cutaneous lesions first arose at the site of and soon after a BCG vaccination. Juvenile sarcoidosis is rare, and the pattern of clinical features is distinct from the adult form of sarcoidosis, possibly related to immunologic development. The cause of sarcoidosis is unknown, although there is much interest in the possibility of mycobacterial species operating as antigenic stimuli to initiate the disease. This case suggests that the Mycobacterium bovis present in the BGC vaccination may have been etiologically important in the development of sarcoidosis. (J Am Acad Dermatol 2003;48:S99-102.)

 

   Publishing and Reprint Information  TOP 


 

 

Vaccination News Home Page

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.